top of page
Menu
Close
HOME
co(ntext)
co(laboratory)
PATIENT CENTRIC APPROACH TO HTA
broader impact of patient advocacy
precision oncology think tank
science
policy
advocacy
knowvember
know the science
know the stories
know the system
who is doing what and test access
co.laterals
CRISIS TO CATALYST
COLAB.CONVERSATIONS
co.llective
co(mmentary)
colab(orate)
co
lab
we are not here to fit in
designed for
systems change
the cancer collaborative
is a catalyst for change, where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
All Posts
science
policy
advocacy
Search
The cost of inaction (on cancer)
Apr 4, 2024
4 min read
the true cost of the economic burden of cancer in canada
Jun 6, 2023
5 min read
Project Orbis. Accelerating time to patient access?
Mar 7, 2023
3 min read
the patented medicines review board has lost its way (again)
Nov 8, 2022
11 min read
open letter: let’s put cancer at the top of the agenda
Nov 7, 2022
1 min read
Cancer deaths must not be a side effect of the pandemic: delays in cancer diagnosis and treatment co
May 25, 2022
3 min read
why precision medicine matters
Nov 17, 2021
3 min read
the importance of biomarker testing
Nov 11, 2021
2 min read
improving access to innovative therapies
Nov 17, 2020
1 min read
#travelwithcolab
Feb 17, 2020
3 min read
if not now, when?
Sep 10, 2019
3 min read
car-t. one year later
Sep 5, 2019
2 min read
biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable
Aug 29, 2019
2 min read
managing expectations
Aug 20, 2019
2 min read
how car-t is an opportunity for canada
Aug 1, 2019
2 min read
biosimilars. the european experience
Jun 21, 2019
3 min read
challenges & potential barriers to CAR-T access
Mar 25, 2019
3 min read
CART
PRECISION MEDICINE
CRISIS TO CATALYST
BIOSIMILARS
COLAB.CONVERSATIONS
colabXchange
precision oncology think tank
co.laterals
co.llective
co(ntext)
colab(orate)
co(mmentary)
CO
LAB
bottom of page